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Novel, multiphasic gene-activated matrices for gradient based multi-gene delivery  
G A Feichtinger1 R Chen2 X Yang1  
1Department of Oral Biology, School of Dentistry, University of Leeds, Leeds, UK 2Faculty of 
Engineering, Department of Chemical Engineering, Imperial College, London, UK  
Regeneration of tissue interfaces requires delivery modalities that can provide multiple instructive 
morphogenic cues in a spatially controlled manner. In order to provide a smart biomaterial that is 
capable of generating gradients of multiple morphogenic cues we aimed at designing hydrogel 
based gene-activated matrices (GAMs) for the nonviral delivery of multiple therapeutic genes in a 
spatially controlled manner. Hydrogels were loaded with multiple plasmid DNAs using a novel 
method for spatially controlled synthesis of DNA/nanoparticle co-precipitates in different areas of 
the gels. Nanoparticles were analyzed by scanning electron microscopy and composition 
confirmed by energy dispersive X-ray spectroscopy (EDX). Transfection efficacies and cell 
compatibility were analyzed in vitro using cell lines and subcutaneous in vivo implantation via 
bioluminescence imaging. Characterization of the agarose GAMs showed pDNA/nanoparticle 
(size ≤ 200nm) formation in the gel in distinct areas, confirming spatial control of loading. EDX 
confirmed these particles as nanocarrier/plasmid DNA coprecipitates. In vitro testing showed no 
substantial toxicity and confirmed enhanced transfection compared to naked DNA loaded 
matrices. In vivo results demonstrated gene delivery and persistent gene expression for more than 
2 weeks and indicated improved gene expression using the complexation strategy. In conclusion 
this initial study demonstrated the generation of therapeutic gene/nanoparticle gradients within a 
hydrogel biomaterial for spatially controlled nonviral gene delivery in vitro and in vivo. The 
developed strategy will be applied in develop- mental engineering approaches in the future using 
gene encoded morphogenic gradients to induce the formation of complex tissue interfaces.  
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